Armotraz also known as Indian Generic ARIMIDEX, is a prescription aromatase inhibitor indicated for:
1. Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer
2.First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer
3.Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to Armotraz
Armotraz’s is a generic prescription medicine from Cipla, which is one of the biggest pharmaceutical company in India.
Warning and Precautions:
In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events occurred with Armotraz use compared to tamoxifen use. Consider risks and benefits
Tamoxifen: Do not use in combination with Armotraz. No additional benefit seen over tamoxifen monotherapy.
Estrogen-containing products: Combination use may diminish activity of Armotraz
|Don't take the drug without consulting a qualified doctor or physician
|Follow the doctor's advice
|Delivery & Returns